These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 37632231)

  • 1. Testicular germ cell tumour cells release microRNA-containing extracellular vesicles that induce phenotypic and genotypic changes in cells of the tumour microenvironment.
    Alonso-Crisostomo L; Trendell J; Ferraresso M; Bailey S; Ward D; Scurlock ZGL; Wenlock SC; Bastos CAP; Jugdaohsingh R; Faria NJ; Enright AJ; Scarpini CG; Coleman N; Murray MJ
    Int J Cancer; 2024 Jan; 154(2):372-388. PubMed ID: 37632231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker.
    Spiekermann M; Belge G; Winter N; Ikogho R; Balks T; Bullerdiek J; Dieckmann KP
    Andrology; 2015 Jan; 3(1):78-84. PubMed ID: 25187505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miRNA-302s may act as oncogenes in human testicular germ cell tumours.
    Das MK; Evensen HSF; Furu K; Haugen TB
    Sci Rep; 2019 Jun; 9(1):9189. PubMed ID: 31235829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
    Ernst S; Heinzelmann J; Bohle RM; Weber G; Stöckle M; Junker K; Heinzelbecker J
    Andrology; 2020 Nov; 8(6):1687-1698. PubMed ID: 32530514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular signatures identified by integrating gene expression and methylation in non-seminoma and seminoma of testicular germ cell tumours.
    Mallik S; Qin G; Jia P; Zhao Z
    Epigenetics; 2021; 16(2):162-176. PubMed ID: 32615059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Levels of MicroRNA miR-371a-3p: A Sensitive and Specific New Biomarker for Germ Cell Tumours.
    Dieckmann KP; Radtke A; Spiekermann M; Balks T; Matthies C; Becker P; Ruf C; Oing C; Oechsle K; Bokemeyer C; Hammel J; Melchior S; Wosniok W; Belge G
    Eur Urol; 2017 Feb; 71(2):213-220. PubMed ID: 27495845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of miR-371a-3p to predict viable germ cell tumor in patients with pure seminoma receiving retroperitoneal lymph node dissection.
    Konneh B; Lafin JT; Howard J; Gerald T; Amini A; Savelyeva A; Woldu SL; Lewis CM; Jia L; Margulis V; Coleman N; Scarpini C; Frazier AL; Murray MJ; Amatruda JF; Bagrodia A
    Andrology; 2023 May; 11(4):634-640. PubMed ID: 36254623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Novel Biomarker of Germ Cell Tumours, Micro-RNA-371a-3p, Has a Very Rapid Decay in Patients with Clinical Stage 1.
    Radtke A; Hennig F; Ikogho R; Hammel J; Anheuser P; Wülfing C; Belge G; Dieckmann KP
    Urol Int; 2018; 100(4):470-475. PubMed ID: 29698973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
    Dieckmann KP; Radtke A; Geczi L; Matthies C; Anheuser P; Eckardt U; Sommer J; Zengerling F; Trenti E; Pichler R; Belz H; Zastrow S; Winter A; Melchior S; Hammel J; Kranz J; Bolten M; Krege S; Haben B; Loidl W; Ruf CG; Heinzelbecker J; Heidenreich A; Cremers JF; Oing C; Hermanns T; Fankhauser CD; Gillessen S; Reichegger H; Cathomas R; Pichler M; Hentrich M; Eredics K; Lorch A; Wülfing C; Peine S; Wosniok W; Bokemeyer C; Belge G
    J Clin Oncol; 2019 Jun; 37(16):1412-1423. PubMed ID: 30875280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours.
    Roška J; Lobo J; Ivovič D; Wachsmannová L; Mueller T; Henrique R; Jerónimo C; Chovanec M; Jurkovičová D
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The present and future of serum diagnostic tests for testicular germ cell tumours.
    Murray MJ; Huddart RA; Coleman N
    Nat Rev Urol; 2016 Dec; 13(12):715-725. PubMed ID: 27754472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of miRNA in Testicular Cancer: Current Insights and Future Perspectives.
    Ditonno F; Franco A; Manfredi C; Fasanella D; Abate M; La Rocca R; Crocerossa F; Iossa V; Falagario UG; Cirillo L; Altieri VM; Di Mauro E; Crocetto F; Barone B; Cilio S; Pandolfo SD; Aveta A; Mirone V; Franzese CA; Arcaniolo D; Napolitano L
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004082
    [No Abstract]   [Full Text] [Related]  

  • 13. MicroRNA and transcription factor co-regulatory networks and subtype classification of seminoma and non-seminoma in testicular germ cell tumors.
    Qin G; Mallik S; Mitra R; Li A; Jia P; Eischen CM; Zhao Z
    Sci Rep; 2020 Jan; 10(1):852. PubMed ID: 31965022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
    Terbuch A; Adiprasito JB; Stiegelbauer V; Seles M; Klec C; Pichler GP; Resel M; Posch F; Lembeck AL; Stöger H; Szkandera J; Pummer K; Bauernhofer T; Hutterer GC; Gerger A; Stotz M; Pichler M
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive microRNA expression analysis of pediatric gonadal germ cell tumors: unveiling novel biomarkers and signatures.
    Santarosa Vieira AG; da Silva LS; Albino da Silva EC; Laus AC; Faria TMV; van Helvoort Lengert A; Martins GE; de Oliveira MA; Reis RM; Lopes LF; Pinto MT
    Mol Oncol; 2024 Jun; 18(6):1593-1607. PubMed ID: 38725152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin.
    Belge G; Grobelny F; Radtke A; Bodes J; Matthies C; Wülfing C; Dieckmann KP
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):435-443. PubMed ID: 33200255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in Differentiation of Embryoid Bodies and the Teratoma Subtype of Testicular Cancer.
    Myklebust MP; Søviknes AM; Halvorsen OJ; Thor A; Dahl O; Ræder H
    Cancer Genomics Proteomics; 2022; 19(2):178-193. PubMed ID: 35181587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating MicroRNAs, the Next-Generation Serum Biomarkers in Testicular Germ Cell Tumours: A Systematic Review.
    Leão R; Albersen M; Looijenga LHJ; Tandstad T; Kollmannsberger C; Murray MJ; Culine S; Coleman N; Belge G; Hamilton RJ; Dieckmann KP
    Eur Urol; 2021 Oct; 80(4):456-466. PubMed ID: 34175151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germ cell tumour subtypes display differential expression of microRNA371a-3p.
    Vilela-Salgueiro B; Barros-Silva D; Lobo J; Costa AL; Guimarães R; Cantante M; Lopes P; Braga I; Oliveira J; Henrique R; Jerónimo C
    Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
    Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
    Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.